Coston, McIsaac & Partners
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1945037
BAR HARBOR, ME
Position in RXRX
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$147
+$55 QoQ
Shares Held
48
+242.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Coston, McIsaac & Partners holds $996 across 6 Biotechnology names. RXRX ranks #3 (14.8% of the industry book) .
All Filings in RXRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $147 | 48 | Shares | Sole | 2026-04-22 | |
| 2024-09-30 | $92 | 14 | Shares | Sole | 2024-10-22 | |
| No filing history on record for this holder in this stock. | ||||||